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Abstract
Background:  The identification of differentially expressed genes (DEGs) from Affymetrix
GeneChips arrays is currently done by first computing expression levels from the low-level probe
intensities, then deriving significance by comparing these expression levels between conditions. The
proposed PL-LM (Probe-Level Linear Model) method implements a linear model applied on the
probe-level data to directly estimate the treatment effect. A finite mixture of Gaussian components
is then used to identify DEGs using the coefficients estimated by the linear model. This approach
can readily be applied to experimental design with or without replication.
Results:  On a wholly defined dataset, the PL-LM method was able to identify 75% of the
differentially expressed genes within 10% of false positives. This accuracy was achieved both using
the three replicates per conditions available in the dataset and using only one replicate per
condition.
Conclusion: The method achieves, on this dataset, a higher accuracy than the best set of tools
identified by the authors of the dataset, and does so using only one replicate per condition.
Background
DNA microarrays are commonly used to measure, in par-
allel, the steady-state concentration of tens of thousands
of mRNAs, providing an estimate of the level of expres-
sion of the corresponding genes. They come in two fla-
vors: 1) spotted arrays allows for the simultaneous
measurement of two samples on the same array, we'll refer
to these arrays as multi-channel arrays; 2) Affymetrix
GeneChips arrays with a significantly higher density but
only allowing for the hybridization of one sample, we'll
refer to those as High-Density Arrays, HDAs. A typical
piece of information that investigators seek to extract from
microarrays is the list of differentially expressed genes
(DEGs) between a treatment and a control condition. This
can either take the form of a defined subset or an ordering
of the whole transcriptome on which some meaningful
(statistically and/or practically) threshold is applied. Until
recently most of the efforts to derive a statistical method
to solve this problem have been focusing on a general
approach applicable to both type of arrays. The strategy
when analyzing HDAs is to estimate the absolute level
expression of a given gene in each condition and then
compute the log-ratio of the expression levels between
two conditions. Methods applied to log-ratios on multi-
channel arrays can readily be applied to these computed
ratios.
A fundamental issue when analyzing microarrays data is
the imbalance between the dimensionality of the data
(tens of thousands of measures for each sample) vs. the
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number of samples or replicates (for most studies
between 2 and 60). On the theoretical side, this imbal-
ance gives rise to the necessity of adjusting statistical
thresholds to the context of multiple testing [1,2], seri-
ously complicating the accurate estimation of sensitivity
and specificity. Because widely used statistical methods
are based on an estimate of the gene-specific variation,
they technically require at least 2 replicates per condi-
tions. In the context of multi-channel arrays, experts in the
field have been recommending the use of 6 replicates [3].
But, for practical reasons, most laboratories have been set-
tling for 3 replicates per condition. Proof-of-principle
experiments with no replication (one array per condition)
are still performed routinely by several labs and typically
analyzed by the simple method of identifying genes as
putative DEGs if they show a ratio above 2 or below 0.5.
In the work presented here, a significant increase in the
accuracy of DEGs detection from a low number of repli-
cate arrays will be obtained by taking advantage of the
design itself of HDAs. All of the Affymetrix GeneChips
contain k pairs of 25-mer DNA oligonucleotides, called
probe pairs, per probe-set. The probe-sets are designed to
measure the expression of a single gene. Each probe pair
is composed of a match (PM) and mismatch (MM) probe,
the former being the exact 25 nucleotides and the later
containing one single mismatch at position 13. MM
probes were introduced to estimate the level of non-spe-
cific hybridization of the corresponding PM probe, but
the recent trend has been to ignore the MM measures and
only use PM measures seeking alternative methods to esti-
mate non-specific hybridization. The measure of interest
being the level of expression of the genes, it is necessary to
transform a set of k probe pair's intensities into a single
probe-set measurement. This step is referred to as the
expression summary. It is still debated which expression
summary method gives the best results but both MAS5.0
[4] and RMA [5] have been widely used. A recent summa-
rization approach, FARMS [6], have been found to com-
pare favorably to more classical summarization
approaches and will be included in the comparisons.
The publication of the Choe et al. dataset in 2005 [7] has
provided an objective benchmark to evaluate the accuracy
of differential gene expression of various combinations of
methods. In this work the authors have amplified 3,866
cRNAs and prepared two samples, 'control' (C) and 'spike'
(S), where 1,331 cRNAs were spiked at various ratios of
concentrations from 1.2 to 4. The two samples were then
hybridized to three Affymetrix GeneChips and scanned
using standard Affymetrix protocol. The work was done
using the Affymetrix Drosophila  array (DrosGenome1)
where each gene is represented by a probe-set of 14 probe
pairs of 25-mer DNA oligonuceotides. There are a total of
14,010 probe-sets present on the array. Two key character-
istics of this dataset will be important to remember when
carrying out the statistical analysis: 1) a large proportion
(72%) of the probe-sets corresponds to cRNAs that were
not present in the samples, leading to a bimodal intensity
distribution; 2) Only concentration ratios above 1 were
introduced in the spiked sample, inducing a strong asym-
metry in the distribution of log-ratios. Using this valida-
tion dataset, it was shown [7] that a preferred set of steps
can be identified to optimize the detection of DEGs in
HDAs. The optimal pipeline identified corresponds to the
use of MAS5.0 for the background correction, probe-level
normalization, PM adjustment and the use of the median-
polish algorithm for expression summaries (borrowed
from RMA[5]), followed by a loess normalization on the
probe-set level data and finally use Cyber-T [8] to identify
DEGs.
The most successful and widely used methods to identify
DEGs are currently based on variations of a regularized t-
statistic where the standard deviation term is weighted [8],
a constant added to it [9,10] or both [11]. Regularization
terms are always, but in various ways, estimated from the
dataset being analyzed to account for experiment-specific
behavior of the data. Recent work from Barrera et al. [12]
attempts to identify DEGs directly from the probe-level
data using a two-way ANOVA approach. Their results sug-
gest that this class of approaches can outperform probe-
set level methods or give comparable results with less rep-
licates, but their validation relies on the use of the Affyme-
trix Latin Square dataset which contains DEGs with
concentration ratios of 2 and above on a small number of
genes (a total of 126 spiked genes). All statistical methods
tested (data not shown) perform well on this dataset and
it is often difficult to quantify slight improvements in
accuracy.
In this paper, I propose a method that scores better accu-
racy than the preferred pipeline identified by Choe et al.
[7] and will demonstrate that this method doesn't require
the three technical replicates provided by the dataset to
correctly identify 75% of the DEGs within 10% of false
positives. The proposed method, called PL-LM (Probe-
Level Linear Model), directly models the treatment effect
versus a baseline control using the probe-level data, using
a linear model. The treatment effect and average intensity
fitted by the linear model are then modeled by a Gaussian
Mixture Model (GMM), which is used to separate the
DEGs from non-DEGs. The outcome of the GMM is the
probability of each probe-set to belong to the cluster of
DEGs, thus the PL-LM method as a whole should be char-
acterized as a feature selection algorithm. This second
stage of the analysis borrows idea introduced by Jia and
Xu [13], where they used a GMM to cluster genes showing
similar expression responses vs. a quantitative phenotype.
The average intensity and treatment effect in PL-LM areBMC Bioinformatics 2006, 7:391 http://www.biomedcentral.com/1471-2105/7/391
Page 3 of 9
(page number not for citation purposes)
equivalent to the βk0 and βk1 in [13]. There are a few fun-
damental differences between the two approaches: 1) in
PL-LM, the optimization of the GMM is decoupled from
the fitting of the linear model, 2) the linear model of PL-
LM is based on probe-level data, and 3) the clustering step
aims essentially at separating DEGs from non-DEGs.
Results and discussion
Data from the Choe et al. [7] dataset was log2-trans-
formed, quantile-normalized [14] and a linear model (see
Methods section) was fit for each probe-set, estimating
parameter T, the treatment effect in equation 2 using a
standard least-square method [15]. Figure 1 presents nor-
malized probe-level data for three typical probe-sets: a) a
probe-set that was spiked at four times the concentration
of the control; b) a probe-set that wasn't spiked, and c) a
probe-set corresponding to a cRNA that wasn't amplified.
For each probe-set the value estimated for the treatment
effect, T, is reported. A first observation that can be made
is the fact that values obtained for T underestimate the
ratio of concentration (T = 1 would be equivalent to a
two-fold ratio). This trend has been also reported by Choe
et al. [7] for other methods on their dataset. It seems to be
either a limitation introduced by the impossibility to
accurately estimate non-specific signal for each probe or a
real bias introduced by the experimental methods to pre-
pare the dataset. Another important observation is that
cRNAs that were not spiked tend to have a negative value
of T, suggesting that they are seen as decreasing in the
spiked vs. the control sample. Examination of the raw
data presented in figure 1b confirms this trend since for
each probe, all three spiked replicates fall below the inten-
sities of the three control replicates. On the other hand,
for probe-set corresponding to cRNAs that were not
amplified the intensities seem to be similar between the
spiked and control samples (figure 1c).
For each probe-set, the average log2 intensity is also deter-
mined by considering all probes and will be referred as I.
To identify DEGs, a mixture model with three Gaussian
components (with variable mean, and full variance matri-
ces) was fitted to the two-dimensional data points defined
by T and I. The number of Gaussian components to use in
the mixture is dictate by the distribution of data points
with respect to T and I as observed from a scatter plot. Fig-
ure 2 shows the result of this model. Upon multiple trials,
starting from random assignations of data points to mix-
ture components, the same classification was obtained
(data not shown). The three mixture components are rep-
resented in figure 2 as ellipses, visually translating the
mixtures parameters. Not shown in the figure, the mixing
proportions of the three components are 17%, 74% and
9%, and can be respectively attributed to non-spiked
probe-sets, not amplified cRNAs and DEGs. Probe-sets
having a conditional probability of belonging to the third
component above 0.5 are identified by larger dots and
grayed out. This conditional probability will be used as
the ordering statistic to compute ROC curves and allows
for an objective comparison with other methods to iden-
tify DEGs. Observations made on the three typical probe-
sets of figure 1 can be seen as widespread among their
classes. There also seem to be a slight intensity-dependant
bias over T that can be observed in all three components.
To assess the accuracy of the ordering induced by the PL-
LM method, ROC curves were computed for results
obtained by using all six arrays from the dataset and for all
combinations of two arrays (one control and one spiked
sample). As a comparison, three other approaches were
applied to the dataset: 1) the preferred pipeline identified
by Choe et al. [7] using the MAS5.0 algorithm [4] but
using the medianpolish as the summarization step, loess
normalization [16] and Cyber-T regularized t-statistic [8];
2) a simple approach combining the RMA expression
summary [5], quantile normalization [14] and absolute
fold-change ordering; 3) the FARMS summarization
method, with the ordering obtained from either the abso-
lute fold-change or by applying the cyber-T approach.
Resulting ROC curves are shown in figure 3. In an attempt
to quantify the overall accuracy of each method, the area
under the curve (AUC) of the ROC curves have been com-
puted and reported in the legend. First, both the PL-LM
(on two or six arrays) and Cyber-T perform equally well
up to the identification of around 800 true positives, after
which the PL-LM significantly outperforms the Cyber-T
method whether using all arrays or a single replicate per
condition. The fold-change method applied to quantile-
normalized RMA summaries, even when using three rep-
licates per condition, performs on a much lower level than
Cyber-T, highlighting a clear necessity for a proper statis-
tical analysis when reporting HDA data, even in the
absence of replication.
To assess if a higher level of analysis on the Cyber-T regu-
larized  t-statistic could help distinguish between DEGs
and non-DEGs, the distribution of this statistic vs. the
average intensity I is presented in figure 4. Spiked probe-
sets are shown as large and dark dots, not amplified
cRNAs as large and light dots, and probe-sets that where
not spiked as small black dots. An interesting feature of
Cyber-T is that it was able to completely remove the inten-
sity-dependant bias on its statistic. But, in doing so, seems
to blur the boundaries between the clusters identified
from the PL-LM method. It is also important to notice that
the clear clustering apparent in figure 2 is revealed only by
the use of the treatment coefficient T and is mostly lost
using probe-set-based statistics.BMC Bioinformatics 2006, 7:391 http://www.biomedcentral.com/1471-2105/7/391
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Conclusion
By adapting and combining previously proposed
approaches (probe-level linear model [12] and treatment
effect clustering [13]), the PL-LM method was able to out-
perform by a significant margin the preferred method
identified by Choe et al. [7] on their validation dataset:
MAS5.0 background correction and PM adjustment,
median polish expression summaries followed by loess
normalization and Cyber-T [8]. Moreover, by using
probe-level data to assess the variability of a differential
expression measure, the PL-LM method maintains its level
of performance on the validation dataset even when only
Examples of probe-level data Figure 1
Examples of probe-level data. a) For a differentially expressed gene (cRNA spiked at 4-fold from the Choe et al. dataset, probe-
set: 147419_at), b) a non-differentially expressed gene (cRNA at equal concentrations, probe-set: 149358_at), and c) a non-
expressed gene (not in the pool of amplified cRNAs, probe-set: 142266_at). Quantile-normalized data from the control (circle) 
and spiked (+) samples are shown, including replicate data. Probes are ordered by the average intensity on the control repli-
cates. For each probe-set, the value of T obtained from the linear model is shown.BMC Bioinformatics 2006, 7:391 http://www.biomedcentral.com/1471-2105/7/391
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one array per condition (control and spike) is used, no
matter which arrays are chosen. These results indicate
that, within the experimental setup used for the validation
study of Choe et al., no replication was necessary to cor-
rectly identify 75% of the DEGs within 10% of false posi-
tives (compared to 69% using Cyber-T and 14% using the
fold-change method).
It is important to qualify the previous statement since the
replicates that were performed in this study were technical
replicates obtained by hybridizing the same pool of
labeled cRNAs to three arrays: the PL-LM method doesn't
require technical replicates to achieve high accuracy. In
several contexts, it will still be recommended to perform
biological replicates to account for possible variations due
to limitations of the experimental protocol (small
amount of material available, uncontrolled biological fac-
tors, etc.). But in general, if each biological sample pro-
vides a statistically sound sampling of the population to
study, this variability should be negligible. Despite being
a controversial technique [17-20], it is possible in practice
to reduce this variability by increasing the amount of RNA
per sample, and can readily be achieved by pooling mul-
tiple samples together. The downside of this approach is
that quantification of the biological variations not due to
the factor of interest is lost, but this loss might be more
than compensated by the reduction in array costs. In fact,
to properly quantify the biological variation and to avoid
relying on a priori assumptions to regularize it, typically
requires a number of arrays that falls well above the
budget of a large number of studies. In the study on pool-
ing carried out by Jolly et al. [17] they compare an ANOVA
analysis performed on probe-set expression levels
obtained from 5 vs. 3 samples with the analysis of pooled
RNA done based on the observed fold-change. They con-
cluded that the pooled strategy should only be used
"where the expected response or phenotype is robust and
its variation in that response is minimal". It is debatable
whether their conclusions stems from the fundamentally
diverging approaches used to analyze the pooled vs. indi-
viduals datasets or if it truly reflects limitations set forth by
the pooling process. The PL-LM method, by being amena-
ble to both multiple and single replicate context, could be
used to remove the method bias when comparing the
pooled vs. non-pooled approach.
The PL-LM method still carries a few drawbacks. The most
limiting aspect is the manual nature of the mixture mod-
eling step: deciding on the number of components and
which component(s) is (are) modeling the DEGs is cur-
rently done by manual inspection of the optimized mix-
ture parameters. In a different context, Jia et al. [13] have
been using the Bayesian information criterion (BIC) to
determine the optimal number of components. The use of
a graphical representation as shown in figure 2 greatly
simplifies this step but, depending on the dataset ana-
lyzed the group separation might be less obvious, and
mostly, the procedure relies on the knowledge of it oper-
ator. It is also a possibility that on a dataset with an
extremely low proportion of DEGs (1 to 10 for example),
the mixture step will require a large number of compo-
nents before dedicating one to the DEGs, complicating
the visual assessment of the mixture model. In such cir-
cumstance, the mixture could be used to model non-
DEGs and an outlier detection approach used to identify
DEGs (see [21]).
In essence, the PL-LM method implements in a single step
the RMA expression summary [5] and the linear model
proposed by Kerr et al. [22]. By quantifying directly the
difference induced by the treatment without the need to
estimate the expression level of a probe-set for each array,
the method achieves, on a wholly defined validation data-
set, better accuracy without any technical replicate. The
reduction in the number of estimated parameters and
possibility to consider across treatments observations
increases the robustness of the approach to quantify the
treatment difference.
Mixture modeling of the PL-LM method on the Choe et al.  dataset Figure 2
Mixture modeling of the PL-LM method on the Choe et al. 
dataset. The three mixture components are represented as 
ellipse identifying their center and variances. Data points with 
a conditional probability of belonging to the component 
modeling DEGs above 0.5 are shown as larger gray dots. The 
mixing proportions of the three components are 17%, 74% 
and 9%, respectively for the non-spiked probe-sets, not 
amplified cRNAs and DEGs.BMC Bioinformatics 2006, 7:391 http://www.biomedcentral.com/1471-2105/7/391
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Methods
Normalization
Two normalization methods were tested as a pre-treat-
ment to PL-LM to remove intensity-dependant bias and
scaling effect: 1) Cyclic loess, introduced by Dudoit et al.
[1], qualitatively performed the best on the Choe et al.
dataset but requires 5 minutes of computation time (5
cycles were applied, all CPU time reported are from a P4
ROC curves comparing methods on the Choe et al. dataset Figure 3
ROC curves comparing methods on the Choe et al. dataset. Probe-sets with a spiked to control concentration ratio above or 
equal to 1.2 were considered as DEGs to compute these curves, resulting in 1,326 spiked probe-sets to identify among a total 
of 14,010. The fold-change applied after RMA summaries and quantile normalization is shown as a baseline for comparison 
since it is a simple and frequently used method. Nine shaded curves, representing the results from applying the PL-LM method 
to all combinations of two arrays (one control vs. one spike), are falling directly under the PL-LM (on all replicates) curve 
(black line). For all methods, the area under the curve (AUC) is reported as a quantitative measure of both sensitivity and spe-
cificity.
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0
Nb. of false positives
N
b
.
 
o
f
 
t
r
u
e
 
p
o
s
i
t
i
v
e
s
Cyber-T (MAS5+loess+medianpolish, 6 chips), AUC = 0.92
Cyber-T (FARMS+loess, 6 chips), AUC = 0.91
PL-LM (log2+quantile, 2 chips)
PL-LM (log2+quantile, 6 chips), AUC = 0.96
fold-change (FARMS+loess, 6 chips), AUC = 0.83
fold-change (RMA+quantile, 6 chips), AUC = 0.81BMC Bioinformatics 2006, 7:391 http://www.biomedcentral.com/1471-2105/7/391
Page 7 of 9
(page number not for citation purposes)
3.2GHz); 2) Quantile normalization, described in Bolstad
et al. [14], requires 10 seconds of computation time and
returns quantitatively equivalent results after applying the
PL-LM and mixture model. Unless stated, all results pre-
sented in this paper were done on a log2-transformed and
quantile-normalized dataset.
Overview of PL-LM
The process of segmenting the genes represented on an
array between DEGs and non-DEGs is a highly debated
subject. Feature selection can actually be broken down
into two distinct steps, a first step seeks to order the genes
from the most susceptible to be a DEG to the least, most
often returning a transformation of the primary data into
a single scalar (called the ordering statistics). As examples,
the log2 fold-change, t-statistics, z-scores, relative differ-
ences and p-values used by various approaches all play
this role. Then, an appropriate threshold should be deter-
mined to separate the DEGs from the non-DEGs. Typical
approaches are the ad hoc choice of a threshold (the two-
fold change rule), ad hoc choice of a number of genes to
consider as DEGs, choice of an upper bound to the false
discovery rate [2], or to the Bonferroni-adjusted p-value.
Contrarily to common belief, the computation of the
ordering statistics doesn't need to be quantitatively accu-
rate, but only its relation to the determined threshold is of
importance. The main feature sought in an ordering statis-
tic is its power to segregate the DEGs from non-DEGs. In
this paper the discussion will be strictly limited to a choice
of statistics since in most practical settings the resources
available for follow-up experiments is the determinant
factor in adjusting the threshold. When the true segmen-
tation between DEGs and non-DEGs is known (as is the
case with the Choe et al. dataset), the use of receiver-oper-
ator characteristic (ROC) curves provides visual assess-
ment of the trade-offs between sensitivity and specificity
of the ordering induced by a statistics without the need for
a specific threshold. The area under the ROC curves
(AUC) have also been computed for the approaches
applied, it provides a quantitative evaluation of the per-
formance of the method.
Linear model fitting has already been explored for the
identification of DEGs in DNA microarray data
[12,22,23]. It represents a flexible framework where a lin-
ear equation can be defined as a function of hidden
parameters to return the observed data. Given enough
data, well known methods [15] exist that are able to esti-
mate values for each parameter that minimize the discrep-
ancies between predicted output of the function and the
observed data. When analyzing microarray data, the
model is designed in such a way that one (or several) of
the hidden parameters represents the treatment effect.
Either this estimated parameter or the p-value returned by
performing hypothesis testing on its value are then used as
the ordering statistic.
The machine learning literature [24] has always been con-
cerned with the concept of over-fitting, which is also
applicable to linear model fitting. This concept states that
using a too simple model (with less hidden parameters)
leads to a systematic bias in the predictions since parts of
the phenomenon to model are not accounted for. On the
other hand, using a too complex model can lead to insta-
bility in the predictions, values of the hidden parameters
are artificially adjusted to fit observed variations that are
actually due to a normal noise. This situation is called
over-fitting and typically arises when the number of
observations becomes small with respect to the number of
hidden parameters to estimate. The main impact of over-
fitting in the context of linear models is a loss of accuracy
in the hidden parameter estimates, which implies local
shuffling on the order induced by the estimated statistic.
An appropriate method to control over-fitting is to settle
for a simpler model when the data is scarce, achieving a
favorable trade-off between the bias introduced by the
simpler model and the variability of the more complex
model.
The PL-LM method uses an extra step on top of the linear
model, finite mixture model [21] are used to transform
the output of the linear model into an ordering statistics
Distribution of the Cyber-T statistic as a function of average  intensity I Figure 4
Distribution of the Cyber-T statistic as a function of average 
intensity I. Spiked probe-sets are shown as large and dark 
gray dots, not amplified cRNAs as large and light gray dots, 
and probe-sets that where not spiked as small black dots.BMC Bioinformatics 2006, 7:391 http://www.biomedcentral.com/1471-2105/7/391
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that can flexibly account for biases introduced by the
experimental design. Since it is a well-known fact that a
finite mixture of Gaussian components can model any
arbitrary distribution, this approach doesn't make any
assumption with respect to distributional properties of
the data analyzed. The EM algorithm [25] implementa-
tion used in this work is the MCLUST software [26] run-
ning under R.
Linear model
The first stage of the PL-LM approach implements a linear
model sharing some level of resemblance to the two-way
ANOVA implemented by Barrera et al. [12] on probe-level
data. Their nomenclature will be used to avoid confusion
and simplify the identification of differences between the
approaches. In the Barrera et al. model, the log2 intensity
observation for probe i of a given probe-set in array k cor-
responding to treatment j is modeled by the following lin-
ear equation:
Yijk = µ + Pi + Tj + PTij + εijk,   (1)
where µ is the level of expression of the gene correspond-
ing to this probe-set, Pi models the effect of each probe
affinity, Tj represents the impact of the treatment j, PTij is
the specific effect of the treatment j on probe i and εijk is
assumed to be normally distributed with a probe-set spe-
cific variance. In context of the Choe et al. dataset (2 treat-
ments, triplicates each), fitting the model for a probe-set
means estimating 1 + 14 + 2 + 28 = 40 parameters from 14
× 6 = 84 data points. In their work, Barrera et al. [12] sug-
gest that decision should be taken by testing the hypothe-
sis of equality between the treatments.
The PL-LM method seeks to first simplify the model to
reduce the possibility of over-fitting the data. To identify
DEGs, only the difference between a treatment and a con-
trol needs to be estimated. The equation is replaced by the
following simplified version:
Yijk = αi + Tj + εijk.   (2)
Here, αi combines both the expression level of the gene
and specific probe affinities, Tj represents the effect of
treatment j. Tj will be constrained to 0 for the control treat-
ment resulting in a simpler interpretation of Tj for the
other treatments, and making the solution to the least-
square formulation unique. The error term εijk will absorb
any probe-treatment specific effect and is assumed to be
normally distributed with a probe-set specific variance.
With this model a total of 14 + 1 = 15 parameters will be
fitted, using standard least-square procedure, from the
same 84 data points. In the context of a single treatment
vs. control, the least-square estimators can be obtained
analytically:
Tj = avgik (Yijk - αi)
= avgik (Yijk) - avgi (αi)
αi = avgjk (Yijk - Tj)
= avgjk (Yijk) - avgj (Tj)
In the context of microarray data analysis, the appropri-
ateness of the normally distributed error term, and thus
the possibility to use least-square fitting procedure, is still
under debate. The use of a mixture modeling step (see
below) in PL-LM to derive the final ordering of the probe-
set allows to account for biases introduced in the fitting of
T, if this bias is shared by all probe-sets or if it is probe-set
intensity-dependant.
This model can readily be extended to experimental
designs testing multiple treatments (having more than
one unconstrained Tj) and can be applied in the absence
of replication. For simplicity, T will be used to refer to the
unique unconstrained Tj appearing in the analysis of the
Choe et al. dataset.
DEGs identification
After fitting the model on experimental observations two
quantities are used to test if the probe-set corresponds to
a DEG or not: T, or the p-value returned by testing if T is
different from zero. In the results section, I will show that
for the Choe et al. dataset there is a significant dependency
between T and the average log2 probe intensity within a
probe-set, I, that makes it unreasonable to use the default
T = 0 as a null hypothesis for all probes.
To compensate this bias, the expected distribution of T
and  I  over all probe-sets is estimated from the results
returned by the linear model. A finite mixture of Gaussian
components is known to be able to approximate any dis-
tribution and was used for this purpose. It is expected that
one or several Gaussian component(s) will be affected to
model probe-sets showing significant treatment effect and
that this (those) component(s) should account for a pro-
portion of the dataset corresponding to the expected frac-
tion of DEGs. In typical microarray experiments, this
fraction is usually assumed to be small (1–5% of the genes
expected to change their level of expression). But in the
validation dataset built by Choe et al. the fraction of DEG
is known to be 9.3% (probe-sets with spiked ratios above
1). Moreover, the non-DEGs are known to fall in two dis-
tinct classes: 18.1% of cRNAs were amplified but kept in
equal concentrations between the two samples and 72.4%
of the cRNAs were not amplified. The segmentation of the
probe-sets in three classes defined by the experimental
setup warrants the use of a mixture of three Gaussians.
And with this model, one Gaussian should be expected toPublish with BioMed Central    and   every 
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model each class of probe-sets. DEGs can then be identi-
fied as the probe-sets with high conditional probabilities
of belonging to the component of the mixture modeling
DEGs, reducing this clustering step to an ordering of the
probe-sets. In the case of real expression data, it is still
unclear how to determine the optimal number of compo-
nents to use and how to determine which component(s)
are modeling the DEGs. Visual inspection of the data and
mixture parameters are currently needed to make those
decisions. A few observations are made in the discussion
section regarding this aspect of the work.
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